» Articles » PMID: 37093069

Simultaneous Resection of Colorectal Cancer and Synchronous Liver Metastases: What Determines the Risk of Unfavorable Outcomes? An International Multicenter Retrospective Cohort Study

Abstract

Background: The use of a simultaneous resection (SIMR) in patients with synchronous colorectal liver metastases (sCRLM) has increased over the past decades. However, it remains unclear when a SIMR is beneficial and when it should be avoided. The aim of this retrospective cohort study was therefore to compare the outcomes of a SIMR for sCRLM in different settings, and to assess which factors are independently associated with unfavorable outcomes.

Methods: To perform this retrospective cohort study, patients with sCRLM undergoing SIMR (2004-2019) were extracted from an international multicenter database, and their outcomes were compared after stratification according to the type of liver and colorectal resection performed. Factors associated with unfavorable outcomes were identified through multivariable logistic regression.

Results: Overall, 766 patients were included, encompassing colorectal resections combined with a major liver resection (n=122), minor liver resection in the anterolateral (n=407), or posterosuperior segments ('Technically major', n=237). Minor and technically major resections, compared to major resections, were more often combined with a rectal resection (29.2 and 36.7 vs. 20.5%, respectively, both P=0.003) and performed fully laparoscopic (22.9 and 23.2 vs. 6.6%, respectively, both P = 0.003). Major and technically major resections, compared to minor resections, were more often associated with intraoperative transfusions (42.9 and 38.8 vs. 20%, respectively, both P = 0.003) and unfavorable incidents (9.6 and 9.8 vs. 3.3%, respectively, both P≤0.063). Major resections were associated, compared to minor and technically major resections, with a higher overall morbidity rate (64.8 vs. 50.4 and 49.4%, respectively, both P≤0.024) and a longer length of stay (12 vs. 10 days, both P≤0.042). American Society of Anesthesiologists grades ≥3 [adjusted odds ratio (aOR): 1.671, P=0.015] and undergoing a major liver resection (aOR: 1.788, P=0.047) were independently associated with an increased risk of severe morbidity, while undergoing a left-sided colectomy was associated with a decreased risk (aOR: 0.574, P=0.013).

Conclusions: SIMR should primarily be reserved for sCRLM patients in whom a minor or technically major liver resection would suffice and those requiring a left-sided colectomy. These findings should be confirmed by randomized studies comparing SIMR with staged resections.

Citing Articles

Comparison of textbook outcomes between laparoscopic and open liver resection for patients with hepatocellular carcinoma: a multicenter study.

Luo S, Qin L, Qiu Z, Xie F, Zhang Y, Yu Y Surg Endosc. 2025; 39(3):2052-2061.

PMID: 39890613 DOI: 10.1007/s00464-025-11577-9.


Surgical Site Infections in Simultaneous Colorectal and Liver Resections for Metastatic Colorectal Adenocarcinoma.

Schleimer L, Hakki L, Seier K, Seo S, Cohen N, Usiak S Ann Surg Oncol. 2024; 32(2):1043-1053.

PMID: 39570297 DOI: 10.1245/s10434-024-16489-x.


Immune dynamics shaping pre-metastatic and metastatic niches in liver metastases: from molecular mechanisms to therapeutic strategies.

Zhu C, Liao J, Liu Y, Chen Z, Chang R, Chen X Mol Cancer. 2024; 23(1):254.

PMID: 39543660 PMC: 11562679. DOI: 10.1186/s12943-024-02171-z.


Predictive risk factors for resection surface-related complications after laparoscopic simultaneous resection of primary colorectal tumor and synchronous liver metastases: a single-center retrospective study.

Une N, Kobayashi S, Kudo M, Sugimoto M, Kitaguchi D, Hasegawa H Surg Endosc. 2024; 38(9):5006-5016.

PMID: 38992282 DOI: 10.1007/s00464-024-10964-y.

References
1.
Tsilimigras D, Sahara K, Hyer J, Diaz A, Moris D, Bagante F . Trends and outcomes of simultaneous versus staged resection of synchronous colorectal cancer and colorectal liver metastases. Surgery. 2021; 170(1):160-166. DOI: 10.1016/j.surg.2021.01.041. View

2.
Driedger M, Yamashita T, Starlinger P, Mathis K, Smoot R, Cleary S . Synchronous resection of colorectal cancer primary and liver metastases: an outcomes analysis. HPB (Oxford). 2021; 23(8):1277-1284. DOI: 10.1016/j.hpb.2021.01.002. View

3.
Mentha G, Majno P, Andres A, Rubbia-Brandt L, Morel P, Roth A . Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Br J Surg. 2006; 93(7):872-8. DOI: 10.1002/bjs.5346. View

4.
Kazaryan A, Rosok B, Edwin B . Morbidity assessment in surgery: refinement proposal based on a concept of perioperative adverse events. ISRN Surg. 2013; 2013:625093. PMC: 3671541. DOI: 10.1155/2013/625093. View

5.
Dindo D, Demartines N, Clavien P . Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004; 240(2):205-13. PMC: 1360123. DOI: 10.1097/01.sla.0000133083.54934.ae. View